Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high costs—often exceeding $1,000 per month—put them out of reach for many Americans whose ...

One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...

Ozempic's meteoric rise has reshaped the landscape of healthcare, retail, and consumer behavior. Its initial popularity as a weight loss ...

Emerging science suggests the impact of a healthy gut extends beyond digestion, influencing other body functions like immune ...

This low-calorie meal plan may help you lose weight, but it may also be tough to get all your daily nutrients — and sustain ...

Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration ...

Death rates linked to obesity-related heart disease nearly tripled in our country over a two-decade span. The rate for men ...

When it comes to weight loss, many of us are looking for something simple, effective, and—most importantly—doable. That’s ...

For decades, health experts have preached the benefits of regular exercise for weight loss, but how much do you really need ...

Plus, studies show that a high-protein diet can help with losing fat and gaining muscle at the same time. Research shows that ...

Amidst a race with its competitors to produce the next smash-hit weight loss drug, Novo Nordisk 's ( NVO 0.15%) stock crashed ...

Novo Nordisk's stock plunges 20% after underwhelming weight-loss trial results for its obesity drug. Analysts say market ...